Treatment of endothelial cell dysfunction in atherosclerosis: a new perspective integrating traditional and modern approaches
Frontiers in Physiology · 26.03.2025 · 16
DOI: 10.3389/fphys.2025.1555118 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Physiology, online erschienen am 26.03.2025. Verfasst von Luqun Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 198 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Natural Sciences, China Postdoctoral Science Foundation, Natural Science Foundation of Shanxi Province.
Abstract (Originalsprache)
Atherosclerosis (AS), a prime causative factor in cardiovascular disease, originates from endothelial cell dysfunction (ECD). Comprising a vital part of the vascular endothelium, endothelial cells play a crucial role in maintaining vascular homeostasis, optimizing redox balance, and regulating inflammatory responses. More evidence shows that ECD not only serves as an early harbinger of AS but also exhibits a strong association with disease progression. In recent years, the treatment strategies for ECD have been continuously evolving, encompassing interventions ranging from lifestyle modifications to traditional pharmacotherapy aimed at reducing risk factors, which also have demonstrated the ability to improve endothelial cell function. Additionally, novel strategies such as promising biotherapy and gene therapy have drawn attention. These methods have demonstrated enormous potential and promising prospects in improving endothelial function and reversing AS. However, it is essential to remain cognizant that the current treatments still present significant challenges regarding therapeutic efficacy, long-term safety, and ethical issues. This article aims to provide a systematic review of these treatment methods, analyze the mechanisms and efficacy of various therapeutic strategies, with the goal of offering insights and guidance for clinical practice, and further advancing the prevention and treatment of cardiovascular diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.
Förderung
- National Institutes of Natural Sciences
- China Postdoctoral Science Foundation
- Natural Science Foundation of Shanxi Province
Zitieren
APA
Yang, L., Li, X., Ni, L., & Lin, Y. (2025). Treatment of endothelial cell dysfunction in atherosclerosis: a new perspective integrating traditional and modern approaches. Frontiers in Physiology, 16. https://doi.org/10.3389/fphys.2025.1555118
Vancouver
Yang L, Li X, Ni L, Lin Y. Treatment of endothelial cell dysfunction in atherosclerosis: a new perspective integrating traditional and modern approaches. Frontiers in Physiology. 2025;16. doi:10.3389/fphys.2025.1555118
BibTeX
@article{Yang2025,
author = {Yang, Luqun and Li, Xinjian and Ni, Lin and Lin, Yuanyuan},
title = {Treatment of endothelial cell dysfunction in atherosclerosis: a new perspective integrating traditional and modern approaches},
journal = {Frontiers in Physiology},
year = {2025},
volume = {16},
doi = {10.3389/fphys.2025.1555118}
}
EUVIMED